MedPath

Acceptance-Based Treatment for Prostate Cancer Distress

Not Applicable
Completed
Conditions
Early Stage Prostate Cancer
Interventions
Behavioral: Acceptance and Commitment Therapy
Registration Number
NCT01594593
Lead Sponsor
Veterans Medical Research Foundation
Brief Summary

Prostate cancer (PCa) is the most common type of cancer in men and the second leading cause of death in American men. Those diagnosed with localized prostate cancer encounter three sources of psychological distress: 1) diagnosis itself, 2) treatment decision making, and 3) the often life-altering side effects of treatment. In addition, patients who choose to undergo active surveillance which focuses on monitoring cancer in lieu of treatment, experience distress related to living with cancer. Acceptance and Commitment Therapy (ACT) is an established psychosocial intervention that has been used extensively for mental health treatment and has shown benefits for various chronic conditions. ACT is a behavioral intervention that focuses on tolerating distress and improving function. This pilot study is designed to test the feasibility of ACT for distress reduction and improved quality of life in patients recently diagnosed with early-stage, localized PCa.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • Localized prostate cancer in Stages I or II
  • Ability to give informed consent
  • Age 18 to 80 years old
  • Willingness to come in for a day long intervention
Exclusion Criteria
  • Acute psychosis
  • Suicidal ideation
  • Homicidal ideation
  • Active substance abuse
  • Dementia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Acceptance and Commitment TherapyAcceptance and Commitment TherapyGroup-based behavioral workshop to address cancer-related distress
Primary Outcome Measures
NameTimeMethod
Number of dropouts6 months

Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who drop out of the active treatment arm.

Number of refusals6 months

Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who refuse the active treatment arm.

Secondary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scalebaseline, post intervention, 2 weeks post intervention, 3 months post intervention
Memorial Anxiety Scale for Prostate Cancerbaseline, post intervention, 2 weeks post intervention, 3 months post intervention

Trial Locations

Locations (1)

VA San Diego Healthcare System

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath